Drawing for TEMBO

USPTO serial 98258214

TEMBO

Reviewed by CopyMark Law Group

Status 807Office Action
Filing date
Status date
Registration date
—
Examiner
BRUNDAGE, DAVID WILLIAM
Law office
TMO LAW OFFICE 112

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Need help with TEMBO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William E. Anderson

William E. Anderson CHRISTENSEN, FONDER, DARDI & HERBERT PLLC11322 86TH AVENUE NORTHMAPLE GROVE, MN 55369United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, formulations, and suspensions for embolization therapy in interventional radiology and oncology in the nature of implantable materials comprised of living tissue, namely, embolic agents; pharmaceutical preparations for embolization therapy in the nature of implants comprised of living tissue, namely, embolic agents; pharmaceutical preparations, namely, embolization therapy preparations for embolization of tumors.ACTIVEJul 9, 2024
010Medical apparatus and instruments for embolization surgery; embolic devices for treating anomalies vasculature of the body; medical device, namely, vascular embolization device; medical device for embolization therapy in interventional radiology and oncology; embolic devices for interventional radiology, namely, interventional oncology and peripheral hemostasis; differentiated particle embolics for embolization surgery; medical device used for vascular embolization procedures; medical device and surgical instrument for use in organ ischemia or infarction interventions; medical device used for embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, control of bleeding due to disease or trauma, organs and segmental embolizations, or occlusion of blood flow in the peripheral vasculature; medical devices, namely, syringes and delivery catheters for the delivery of embolic agents delivered through a microcatheter under fluoroscopic control; kits for use in medical and surgical procedures comprised primarily of embolic particles; medical apparatus comprising a system for vascular embolization procedures in the nature of catheters for use in embolization procedures; embolic devices and kits comprising syringes, pouches, and caps for vascular embolization and peripheral hemostasis namely, an embolization therapy system, featuring embolic particles.ACTIVEJul 9, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (GNRN): A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

DateCodeEventWhat it means
Sep 11, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 11, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 11, 2026CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 25, 2026DOCKASSIGNED TO EXAMINER—
Aug 11, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jun 17, 2026IUAFUSE AMENDMENT FILED—
Jun 17, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Dec 11, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 10, 2025EX2GSOU EXTENSION 2 GRANTED—
Dec 10, 2025EXT2SOU EXTENSION 2 FILED—
Dec 10, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 26, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 26, 2025EX1GSOU EXTENSION 1 GRANTED—
Apr 26, 2025EXT1SOU EXTENSION 1 FILED—
Apr 25, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 17, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 5, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 5, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 16, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 24, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 17, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 17, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 17, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 17, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 17, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 17, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 15, 2024DOCKASSIGNED TO EXAMINER—
Dec 5, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 10, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance